Financial statements Natural Cell Therapy
Balance sheet of Natural Cell Therapy
Company age:
Age:
10 y. 5 m. 4 d.
Share capital:
Share capital:
109 400 PLN
Balance sheet data of NATURAL CELL THERAPY
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 787 402,53 | 787 402,53 | 787 402,53 |
| A. Fixed assets | 660 198,72 | 660 198,72 | 660 198,72 |
| B. Current assets | 127 203,81 | 127 203,81 | 127 203,81 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 787 402,53 | 787 402,53 | 787 402,53 |
| A. Equity | 67 407,09 | 67 407,09 | 67 407,09 |
| B. Liabilities and provisions for liabilities | 719 995,44 | 719 995,44 | 719 995,44 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.